Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: February 7, 2023

Patent: 10,081,681

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Summary for Patent: 10,081,681
Title:Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumors
Abstract: Provided are methods for clinical treatment of tumors (e.g., advanced solid tumors) using an anti-LAG-3 antibody in combination with an anti-PD-1 antibody.
Inventor(s): Korman; Alan J. (Piedmont, CA), Lonberg; Nils (Woodside, CA), Fontana; David J. (Clyde Hill, WA), Gutierrez; Andres A. (Lawrenceville, NJ), Selby; Mark J. (San Francisco, CA), Lewis; Katherine E. (Lake Forest Park, WA)
Assignee: Bristol-Myers Squibb Company (Princeton, NJ)
Application Number:15/021,102
Patent Claims:see list of patent claims

Details for Patent 10,081,681

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Bristol-myers Squibb Company YERVOY ipilimumab Injection 125377 03/25/2011 See Plans and Pricing 2033-09-20
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.